BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34789073)

  • 1. Prognostic significance of ferroptosis-related genes and their methylation in AML.
    Zhou F; Chen B
    Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.
    Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y
    J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
    Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
    Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
    Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
    Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
    Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB
    J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.
    Yang XY; Jin J; Huang J; Li P; Xue JW; Wu XJ; He ZX
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7324-7334. PubMed ID: 32706071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
    Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis.
    Wang J; Dao FT; Yang L; Qin YZ
    Sci Rep; 2020 Nov; 10(1):19037. PubMed ID: 33149230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
    Zhang Q; Han Q; Zi J; Song C; Ge Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia.
    Huang X; Zhou D; Ye X; Jin J
    Bosn J Basic Med Sci; 2022 Jul; 22(4):608-628. PubMed ID: 34784264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.